Furthermore, the FCPLJ treatment has also downregulated the genes associated with the endothelial cell biology (ITGB3, ICAM1 and FN1) that are involved in the endothelial permeability process during dengue virus infection [45]. This evidence concerns the gene ICAM1 and dengue disease.